Trials / Sponsors / Paolo Ghia
Paolo Ghia
Academic / Other · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens Chronic Lymphocytic Leukemia | Phase 4 | 2023-11-01 |
| Recruiting | Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Tr Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2022-09-19 |
| Recruiting | Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL Chronic Lymphocytic Leukemia | Phase 2 | 2021-12-13 |
| Unknown | Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemi Chronic Lymphocytic Leukemia | Phase 2 | 2017-11-08 |